https://www.selleckchem.com/pr....oducts/zidesamtinib.
8 %. Using a score 5 instead of 4 to rule out malignancy improved our diagnostic ability to correctly identify 100 % benign lesions. Applying Kaiser score correctly downgraded 60.8 % (17/28) lesions; thus avoiding biopsies in these. Using a high cut-off value8 to rule-in malignancy, we correctly identified 59.7 % of lesions with 80 % specificity and positive likelihood ratio of 3. The Kaiser score has clinical translation benefits when used as a problem-solving tool for inconclusive MG findings. The Kaiser score has cli
Like
Comment
Share
